QT
TSVT

Quantamental Technologies’s 2seventy bio TSVT Stock Holding History

Quantamental Technologies’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$74.9K Buy
+19,109
New +$125K 0.07% 266

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Quantamental Technologies's TSVT Position: Q3 2023 in Review

Quantamental Technologies opened a new position in 2seventy bio (TSVT) in Q3 2023: 19,109 shares worth $74.9K. The stake represents 0.07% of the portfolio and ranks #266 among its holdings.

145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Quantamental Technologies held 19,109 shares of 2seventy bio worth $74.9K as of Q3 2023.
  • 2seventy bio was a new Quantamental Technologies position in Q3 2023.
  • 2seventy bio made up 0.07% of Quantamental Technologies's portfolio in Q3 2023, its #266 holding.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.